Skip to content

Use of Online Personalized Health Record System to Promote Self-Management of Diabetes

Patient-Centered Online Disease Management Using a Personal Health Record System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00542204
Acronym
EMPOWER-D
Enrollment
415
Registered
2007-10-10
Start date
2008-03-31
Completion date
2011-08-31
Last updated
2015-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

Diabetes, Blood Glucose Self-Monitoring, Home Blood Glucose Monitoring, Internet, Personal Health Record (PHR), Health Information Technology (HIT), Care management, Disease Management, Diabetes self-management, Consumer Health Information, Medical Records Systems, Computerized, Computerized Medical Records System, Automated Medical Records System, Electronic Health Record (EHR), Remote patient monitoring

Brief summary

Diabetes is a major, growing, and costly chronic disease in the U.S., and implementation of recommended diabetes care remains poor, not merely suboptimal, and varied for a sizable proportion of Americans with diabetes. To further reduce the treatment and adherence gaps in diabetes care, the researchers propose to evaluate a Customized, Continuous Care Management (CCCM) program that actively supports a partnership between the patient and his/her multidisciplinary care management (CM) team using an online disease management (ODM) system, which is integrated with a comprehensive electronic health record (EHR) system that includes a personal health record and secure patient-clinician messaging capabilities. The CCCM program builds upon CM strategies proven effective in past studies and creates an ODM system that is built upon and fully integrated with a leading, commercially available EHR product - providing a blueprint for instituting customized, continuous care management for many different chronic conditions in a range of ambulatory care settings.

Interventions

BEHAVIORALOnline disease management

The Personalized Health Care Program couples a multidisciplinary care management team with an EHR-integrated Online Disease Management (ODM) system.

Sponsors

Agency for Healthcare Research and Quality (AHRQ)
CollaboratorFED
Sutter Health
CollaboratorOTHER
Palo Alto Medical Foundation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \>= 18 years of age * Have a designated Palo Alto Medical Foundation Primary Care Provider (PCP) * Seen in primary or specialty care at the Palo Alto Division at least once in the preceding 24 months * Diagnosis of diabetes * Baseline A1C \>= 7.5%

Exclusion criteria

* Initial diagnosis of diabetes within the last 12 months * Diagnosis of Type 1 diabetes * Inability to speak and read in English * Lack of regular access to a computer with Internet and email capabilities * Unwilling to perform any self-monitoring at home, including blood glucose and blood pressure% * Pregnant, planning to become pregnant, or lactating * Currently enrolled in a care management program at Palo Alto Medical Foundation or elsewhere * PCP determination that the study is inappropriate or unsafe for the patient * Investigator discretion for clinical safety or protocol adherence reasons

Design outcomes

Primary

MeasureTime frame
Hemoglobin A1CBaseline, 6 months and 12 months

Secondary

MeasureTime frame
Self-management practices(e.g., medication adherence, home monitoring of glucose and BP, diet, and exercise)Baseline, 6 months and 12 months
Processes of care (e.g., frequency of lab testing)Baseline, 6 months and 12 months
Cardiovascular risk (e.g., blood pressure and lipids)Baseline, 6 months and 12 months
Patient experience and satisfaction (e.g., relevant CAHPS measures)Baseline and 12 months
Patient psychosocial well-being (e.g., diabetes-related emotional distress)Baseline, 6 months and 12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026